DE69834194D1 - Oberfläche-exponierte proteine von chlamydia pneumoniae - Google Patents

Oberfläche-exponierte proteine von chlamydia pneumoniae

Info

Publication number
DE69834194D1
DE69834194D1 DE69834194T DE69834194T DE69834194D1 DE 69834194 D1 DE69834194 D1 DE 69834194D1 DE 69834194 T DE69834194 T DE 69834194T DE 69834194 T DE69834194 T DE 69834194T DE 69834194 D1 DE69834194 D1 DE 69834194D1
Authority
DE
Germany
Prior art keywords
proteins
kda
chlamydia pneumoniae
pneumoniae
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834194T
Other languages
English (en)
Other versions
DE69834194T2 (de
Inventor
Svend Birkelund
Gunna Christiansen
Katrine Knudsen
Pedersen Anna-Sofie Hebsgaard
Per Mygind
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOKE DIAGNOSTICS APS RISSKOV
Original Assignee
LOKE DIAGNOSTICS APS RISSKOV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOKE DIAGNOSTICS APS RISSKOV filed Critical LOKE DIAGNOSTICS APS RISSKOV
Application granted granted Critical
Publication of DE69834194D1 publication Critical patent/DE69834194D1/de
Publication of DE69834194T2 publication Critical patent/DE69834194T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/125—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69834194T 1997-06-23 1998-06-19 Oberfläche-exponierte proteine von chlamydia pneumoniae Expired - Lifetime DE69834194T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23
DK74497 1997-06-23
PCT/DK1998/000266 WO1998058953A2 (en) 1997-06-23 1998-06-19 Surface exposed proteins from chlamydia pneumoniae

Publications (2)

Publication Number Publication Date
DE69834194D1 true DE69834194D1 (de) 2006-05-24
DE69834194T2 DE69834194T2 (de) 2007-03-29

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834194T Expired - Lifetime DE69834194T2 (de) 1997-06-23 1998-06-19 Oberfläche-exponierte proteine von chlamydia pneumoniae

Country Status (13)

Country Link
US (2) US7264941B1 (de)
EP (1) EP1007685B1 (de)
JP (1) JP4160640B2 (de)
CN (1) CN1249233C (de)
AT (1) ATE323164T1 (de)
AU (1) AU749382B2 (de)
BR (1) BR9810288A (de)
CA (1) CA2294651A1 (de)
DE (1) DE69834194T2 (de)
DK (1) DK1007685T3 (de)
ES (1) ES2264810T3 (de)
PT (1) PT1007685E (de)
WO (1) WO1998058953A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1129202A2 (de) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia polypeptiden und entspechende dna fragmenten und anwendungen davon
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) * 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ512308A (en) * 1998-12-01 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
AU775695B2 (en) 1999-03-12 2004-08-12 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2373021A1 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
JP4667694B2 (ja) * 1999-09-20 2011-04-13 サノフィ、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
EP1297005B1 (de) * 2000-07-03 2009-08-26 Novartis Vaccines and Diagnostics S.r.l. Immunisierung gegen chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US11091792B2 (en) * 2016-05-04 2021-08-17 Children's Hospital & Research Center At Oakland Rapid extraction of nucleic acids from clinical samples for downstream applications
JP2022532050A (ja) * 2019-05-06 2022-07-13 アロセル エービー 呼吸器感染の検出および分類

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
ES2321346T3 (es) 1994-09-20 2009-06-04 Hitachi Chemical Co., Ltd. Polinucleotidos que codifican un polipeptido antigenico de chlamydia pneumoniae.
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
CA2294651A1 (en) 1998-12-30
JP4160640B2 (ja) 2008-10-01
DK1007685T3 (da) 2006-08-14
EP1007685B1 (de) 2006-04-12
PT1007685E (pt) 2006-08-31
ATE323164T1 (de) 2006-04-15
US7264941B1 (en) 2007-09-04
DE69834194T2 (de) 2007-03-29
EP1007685A2 (de) 2000-06-14
WO1998058953A2 (en) 1998-12-30
ES2264810T3 (es) 2007-01-16
US20080226679A1 (en) 2008-09-18
WO1998058953A3 (en) 1999-03-18
CN1249233C (zh) 2006-04-05
CN1261403A (zh) 2000-07-26
AU749382B2 (en) 2002-06-27
AU8011998A (en) 1999-01-04
BR9810288A (pt) 2000-09-19
JP2002510970A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
RU2339646C2 (ru) Гибридная и тандемная экспрессия белков нейссерий
DE69834194D1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
FI20031199A (fi) Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia
HUP0301003A2 (hu) Kazeinből származó peptidek és terápiás alkalmazásuk
WO2002090502A3 (en) Highly conserved proteins from gram-positive bacteria
EP1613345A4 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
HK1090085A1 (en) Novel photobacterium damselae nucleotide and amino acid sequences and uses thereof
DE60126602D1 (de) Neue collectine
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
MX9805158A (es) Adn que codifica una proteina activadora de plasminogeno.
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
WO2004053117A3 (en) Serine protease
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
AU2001239262A1 (en) Haemophilus influenza outer membrane protein and use thereof in vaccination
WO2002050116A3 (en) Adhesion molecule protein
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
BR0107799A (pt) Proteìna de interação de wt1 wtip
WO2002046380A3 (en) Protein kinase
WO2002062845A3 (en) Adhesion molecules
WO2002034901A8 (en) Protein kinase
WO2002008393A3 (en) Serine protease from yersinia enterocolitica
ATE286535T1 (de) Regulatorisches protein pke 83 aus humanen keratinozyten
TH57274B (th) การก่อภูมิคุ้มกันของวัวนมด้วยโปรตีน GapC ต่อต้านการติดเชื้อ สเทรปโทคอกคัส
WO2002062976A3 (en) Serine proteases

Legal Events

Date Code Title Description
8364 No opposition during term of opposition